Literature DB >> 14687673

From artificial cerebro-spinal fluid (aCSF) to artificial extracellular fluid (aECF): microdialysis perfusate composition effects on in vivo brain ECF glucose measurements.

Ewan C McNay1, Robert S Sherwin.   

Abstract

Microdialysis (mD) is the predominant technique for measurements of brain chemistry, especially when such measurements are made in awake animals. Relatively little attention has been paid, however, to the potential effect on such measurements of variation in the perfusate solution used. Here, we report that small variations in the ionic composition of microdialysis perfusate produced four-fold differences (0.53-2.18 mM) in the results obtained when measuring brain extracellular fluid (ECF) glucose. These changes may be linked to concomitant alterations of local neural activity caused by the perfusate composition. In addition to perfusate composition, probe type also proved to have a significant impact on microdialysis measurements. Further, we report the first direct microdialysis measurements of brain ECF ionic composition, showing significant differences from that of the cerebro-spinal fluid (CSF). Modifying the ionic composition of microdialysis perfusate based on these measurements resulted in a measured hippocampal ECF glucose level of 1.26 +/- .04 mM. Increased understanding of the impact of differences in the perfusate solutions used by different laboratories may provide a basis for reconciliation of apparently disparate microdialysis results within the literature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687673     DOI: 10.1016/j.jneumeth.2003.08.014

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  28 in total

1.  Regional glucose metabolism and glutamatergic neurotransmission in rat brain in vivo.

Authors:  Robin A de Graaf; Graeme F Mason; Anant B Patel; Douglas L Rothman; Kevin L Behar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

2.  Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance.

Authors:  Ewan C McNay; Cecilia T Ong; Rory J McCrimmon; James Cresswell; Jonathan S Bogan; Robert S Sherwin
Journal:  Neurobiol Learn Mem       Date:  2010-02-20       Impact factor: 2.877

3.  Hippocampal insulin microinjection and in vivo microdialysis during spatial memory testing.

Authors:  Ewan C McNay; Leslie A Sandusky; Jiah Pearson-Leary
Journal:  J Vis Exp       Date:  2013-01-11       Impact factor: 1.355

4.  Insulin modulates hippocampally-mediated spatial working memory via glucose transporter-4.

Authors:  J Pearson-Leary; V Jahagirdar; J Sage; E C McNay
Journal:  Behav Brain Res       Date:  2017-09-21       Impact factor: 3.332

5.  Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory.

Authors:  Jiah Pearson-Leary; Ewan C McNay
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

6.  Antibody-enhanced microdialysis collection of CCL2 from rat brain.

Authors:  Anthony W Herbaugh; Julie A Stenken
Journal:  J Neurosci Methods       Date:  2011-05-11       Impact factor: 2.390

7.  Elevated glucose metabolism in the amygdala during an inhibitory avoidance task.

Authors:  Leslie A Sandusky; Robert W Flint; Ewan C McNay
Journal:  Behav Brain Res       Date:  2013-02-15       Impact factor: 3.332

8.  Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.

Authors:  Gregory A Moy; Ewan C McNay
Journal:  Physiol Behav       Date:  2012-12-06

9.  Characterization of conjugated polymer actuation under cerebral physiological conditions.

Authors:  Eugene Dariush Daneshvar; Elisabeth Smela
Journal:  Adv Healthc Mater       Date:  2014-02-24       Impact factor: 9.933

Review 10.  Establishing a physiological environment for visualized in vitro brain slice recordings by increasing oxygen supply and modifying aCSF content.

Authors:  Norbert Hájos; Istvan Mody
Journal:  J Neurosci Methods       Date:  2009-06-12       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.